RANTES and MCP-1 chemokine plasma levels in chronic renal transplant dysfunction and chronic renal failure

Clinical Biochemistry

Volumn 32, Issue 6, 1999, Pages 455-460

  Corsi, Massimiliano M ^a,b   Leone, Giorgio ^c   Fulgenzi, Alessandro ^d   Wasserman, Ken ^e   Leone, Francesco ^c   Ferrero, Maria Elena ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chronic dysfunction; Kidney transplantation; MCP 1; RANTES

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL INFILTRATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; SERODIAGNOSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RANTES; REFERENCE VALUES;

EID: 0032699080     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00038-7     Document Type: Article

References (28)

1. Schlondorff D., Nelson P.J., Luckow B., Banas B. Chemokines and renal disease. Kidney Int. 51:1998;610-621.
2. Baggiolini M. Chemokines and leukocyte traffic. Nature. 392:1998;565-568.
3. Rutledge B.J., Rayburn H., Rosenberg R., et al. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol. 155:1995;4838-4843.
4. Kondo T., Novick A.C., Toma H., Fairchild R.L. Induction of chemokine gene expression during allogenic skin graft rejection. Transplantation. 61:1996;1750-1757.
5. Strhlau J., Pavlakis M., Lipman M., et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA. 94:1997;695-700.
6. Crimm P.C., Rush D.N., Stern E., Jeffery J.R., McKenna R. Chemokine gene expression (RANTES and MIP-1beta) in asymptomatic human renal allograft rejection. J Am Soc Nephrol. 6:1995;1057. (Abst).
7. Nadeau K.C., Azuma H., Tilney N.L. Sequential cytokine dynamics in chronic rejection of rat renal allografts role for cytokines RANTES and MCP-1 . Proc Natl Acad Sci USA. 92:1995;8729-8733.
8. Wedermann C.J., Kowald E., Reinish N., et al. Monocyte haptotaxis induced by the RANTES chemokine. Curr Biol. 3:1993;735-739.
9. Sckall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 347:1990;669-671.
10. Carr M.W., Roth S., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA. 91:1994;3652-3656.
11. Kutukculer N., Clark K., Rigg K.M., et al. The value of posttransplant monitoring interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation. 59:1995;333-340.
12. Adams D.H., Hubscher S., Fear J., Johnson J., Shaw S., Afford S. Hepatic expression of macrophage inflammatory protein-1α and macrophage protein-1β after liver transplantation. Transplantation. 61:1996;817-825.
13. Dalmann M.J. Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol. 5:1993;788-793.
14. Pattison J., Nelson P.J., Huie P., et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet. 343:1994;209-211.
15. Adams D.H., Tilney N.L. The pathobiology of chronic rejection. Morris P.J., Tilney N.L. Transplantation reviews. Vol. 3:1989;131-145 WB Saunders, Philadelphia.
16. Gjertson D.W. Survival trends in long-term first cadaver-donor kidney transplants. Terasaki P.I., Cecka J. Clinical transplants. 1991;225-235 UCLA Tissue Typing Laboratory, Los Angeles.
17. Tilney N.L., Whitley W.D., Diamond J.R., Kupiec-Weglinski J.W., Adams D.H. Chronic rejection, an undefined conundrum. Transplantation. 52:1991;389-398.
18. Paul L.C., Chea R., Kingma I., Davidoff A., Benediktsson H. Intragraft hemodynamic factors in chronic renal transplant rejection. Transplant Proc. 24:1995;2574-2575.
19. Hayry P., Mennander A., Yilmaz S., et al. Towards understanding the pathophysiology of chronic rejection. Clin Invest. 70:1992;780-790.
20. von Luettichau I., Nelson P.J., Pattison J.M., et al. RANTES chemokine expression in diseases and normal human tissue. Cytokine. 8:1996;89-98.
21. Purie M.B., Randolph G.J. Chemokines and tissue injury. Am J Pathol. 146:1995;1287-1301.
22. Baan C.C., Weimar W. Intragraft cytokine gene expression implications for clinical transplantation . Transplant Int. 11:1998;169-180.
23. Rovin B.H., Dickerson J.A., Tan L.C., Hebert C.A. Activation of nuclear factor-kappa B correlates with MCP-1 expression by human mesangial cells. Kidney Int. 48:1995;1263-1271.
24. Grandaliano G., Gesualdo L., Ranieri E., Monno R., Stallone G., Schena F.P. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation. 63:1997;414-420.
25. Vieira J., Schall T.J., Corey L., Geballe A.P. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol. 72:1998;8158-8165.
26. Bodaghi B., Jones T.R., Zipedo D., et al. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy withdrawal of chemokines from the environment of cytomegalovirus-infected cells . J Exp Med. 188:1998;855-866.
27. Mukaida N., Zachariae C.C., Gusella G.L., Matsushima K. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J Immunol. 146:1991;1212-1215.
28. Stellato C., Beck L.A., Gorgone G.A., et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line Modulation by cytokines and glucocorticoids . J Immunol. 155:1995;410-418.